- /
- Supported exchanges
- / US
- / CBLL.NASDAQ
CeriBell, Inc (CBLL NASDAQ) stock market data APIs
CeriBell, Inc Financial Data Overview
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with CeriBell, Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get CeriBell, Inc data using free add-ons & libraries
Get CeriBell, Inc Fundamental Data
CeriBell, Inc Fundamental data includes:
- Net Revenue: 89 063 K
- EBITDA: -57 061 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-03
- EPS/Forecast: -0.41
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CeriBell, Inc News
New
CeriBell Q4 Revenue Rises 34%; Projects Revenue Growth Of 25%-29% For FY'26
(RTTNews) - CeriBell, Inc. (CBLL), a commercial-stage medical technology company, reported an increase in revenue for the fourth quarter and full year of 2025, and also provided revenue guidance for f...
CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue Estimates
CeriBell, Inc. (CBLL) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $0.4 per share a year ago. These figures are ...
CeriBell, Inc. Q4 2025 Earnings Call Summary
CeriBell, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Performance and Market Expansion Achieved 36% annual revenue growth driven by disciplined execution and the predictable, recurring natur...
CeriBell (CBLL) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool. DATE Tuesday, February 24, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer & Co-Founder — Xingjuan Chao Chief Financial Officer — Scott Blumberg V...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.